Table 1.

Inclusion and exclusion criteria

Inclusion criteria	Exclusion criteria
Age between 18 and 70	Diabetes mellitus
	Chronic kidney disease stage IV-V (eGFR <30 ml/min/1.73m2)
	History of transplantation
	History of acute kidney injury before randomization
	Active infection
Cancer patients treated with intravenous cisplatin	Use of other nephrotoxic agents such as nonsteroidal anti-inflammatory drugs, aminoglycosides, colistin, vancomycin, cyclosporine, tacrolimus
	Receiving contrast media during last 72 h
	Liver disease (bilirubin >2 mg/dl, transaminase levels >2.5 times the upper limit normal)
Written consent	Patients with high risks of dehydration owing to poor oral intake
	High blood pressure (>180/110 mmHg despite antihypertensive medications)
	Hypersensitivity to gemigliptin or its excipients
	Low compliance to gemigliptin treatment

Abbreviation: eGFR estimated glomerular filtration rate